Combined typical and atypical long-acting injectable antipsychotics in treatment-resistant schizophrenia: Two cases

Psychiatry Clin Neurosci. 2019 Mar;73(3):140. doi: 10.1111/pcn.12801. Epub 2018 Dec 19.

Authors

Fang-Ling Li¹, Ta-Chuan Yeh², Fu-Chi Yang³, Chih-Sung Liang^{1

4}

Affiliations

¹ Department of Psychiatry, Beitou Branch, Taipei, Taiwan.
² Department of Psychiatry, Tri-Service General Hospital, School of Medicine, Taipei, Taiwan.
³ Department of Neurology, Tri-Service General Hospital, School of Medicine, Taipei, Taiwan.
⁴ Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.

PMID: 30474344
DOI: 10.1111/pcn.12801

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antipsychotic Agents / therapeutic use*
Aripiprazole / therapeutic use*
Drug Therapy, Combination
Female
Flupenthixol / therapeutic use*
Humans
Male
Middle Aged
Paliperidone Palmitate / therapeutic use*
Schizophrenia / drug therapy*
Treatment Outcome

Substances

Antipsychotic Agents
Aripiprazole
Flupenthixol
Paliperidone Palmitate